Prostate cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prostate cancer}} | {{Prostate cancer}} | ||
{{CMG}} | |||
==Overview== | |||
Prostate cancer must be differentiated from [[benign prostatic hypertrophy]], prostatic [[sarcoma]], and direct invasion of the prostate by [[rectal]] [[adenocarcinoma]]. | |||
==Differential diagnosis== | |||
Differential diagnosis of prostate cancer listed below: | |||
* [[Benign prostatic hypertrophy]] (BPH) | |||
* Prostatic [[sarcoma]] | |||
* Direct invasion of the prostate by [[rectal]] [[adenocarcinoma]] | |||
==References== | ==References== |
Revision as of 15:19, 14 September 2015
Prostate cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prostate cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Prostate cancer differential diagnosis |
Risk calculators and risk factors for Prostate cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Prostate cancer must be differentiated from benign prostatic hypertrophy, prostatic sarcoma, and direct invasion of the prostate by rectal adenocarcinoma.
Differential diagnosis
Differential diagnosis of prostate cancer listed below:
- Benign prostatic hypertrophy (BPH)
- Prostatic sarcoma
- Direct invasion of the prostate by rectal adenocarcinoma